News

CURE2h
Imfinzi Combination Shows Efficacy in Bladder Cancer Treatment
Dr. Matthew Galsky discusses the FDA approval of Imfinzi and chemo before and after surgery for muscle-invasive bladder ...
Kymera Therapeutics Announces First Patient Dosed in BROADEN Phase 1b Atopic Dermatitis Clinical Trial of KT-621, a First-in-Class Oral STAT6 Degrader
Data from the BroADen Phase 1b atopic dermatitis (AD) patient trial expected to be reported in 4Q25Completed SAD/MAD dosing in KT-621 Phase 1 ...
GALDERMA LAUNCHES "SCRATCH RESISTANCE" CAMPAIGN TO VALIDATE THE PHYSICAL AND EMOTIONAL BURDENS OF ATOPIC DERMATITIS
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the launch of "Scratch Resistance," its new ...
Revolutionizing Atopic Dermatitis 2025 heads to Nashville, delivering cutting-edge insights for dermatology professionals
Conference 2025 takes place June 6–7 at the DoubleTree by Hilton Hotel Nashville Downtown Held in partnership with HCPLive® ...